Document Page: First | Prev | Next | All | Image | This Release | Search

File: 123096_sep96_decls23_0048.txt
Page: 0048
Total Pages: 52

Subject: DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANCE               

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: DIAGNOSIS AND TREATMENT OF DISEASES  1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS                

Document Number:          1

Folder Seq  #:         88









                     Specific LabomtoEy Diagnosis: Ygrsinia @i @ be readily cultured from blood,
             sputum, and bubo aspirates. Presumptive diagnosis cm be made by gram stain and               (if                         typhoidal tularemia, a syndrome expected to have a caw-fatality rate which may be higher
             available) immunofluorescent staining. Most naturally-mcurring s@ns of Y.                    produce                     than the 5-10% seen when disease is acquired naturally.
             an 'Fl' antigen in-vivo, which can be detected in semm mmples by immunoasmys available
             in field diagnostic laboratories.                                                                                                Clinical Features: A variety of clinical forms of tularemia are seen, depending open
                                                                                                                                      the route of inoculation and vimlence of the strain. Since the infectious do@ is low (1-10
                                                                                                                                      organisms by aerosol or intmdermal routes), ul@roglmdulu, typhoidal, or pharyngeal foriii@
                     C.      'HIERAPY                                                                                                 could be seen. Ulceroglmdul@ tularemia generally occurs about 3 days after exposure
                                                                                                                                      (range, 2-10 days), and manifests as regional lymphadenopathy, fever, chills, headache, and
                     Plague pneumonia is highly contagious. Patients should be managed in strict                                      malaise, with or without a cutaneous ulcer. With typhoidal disease, the systemic clinical
ated. Uiitrntcd      bubonic                     manifestations are similar to those seen in the ulceroglmdular form, but there is no skin
             plague has a ca@-fatality rate commonly reported as around 50%; untreated primary                                        lesion or adenopathy. Typhoidal tularemia is the form of dismw which occurs after
             septicemic and pneumonic plague are invariably fatal. Streptomycin is the preferred                                      inhalation of organisms; in this form, clinically and mdiologically evident pneumonia may bc
             treatment, although tetracyclines, and chlommphenicol also are highly effective if begun                                 significant. Three to five days following inhalation, the abrupt onset of fever, chills,
             early (within 8-24 hours in pneumonic plague). Intramuscular streptomycin (I gm q 12                                     headache, myalgia, and prostration are seen, with a non-productive cough. Deposition of
             hours), intravenous doxycyline (200 mg initially, followed by 100 mg q 12 hours), or                                     organisms in the orophyarynx may also produce a pharynygeal form of tularemia, with
             intravenous chlommphenicol (I gm q 6 hours) for 10-14 days are rmognized as effective                                    ..ulcerogindulu" -type lesions Imalized to the throat.
             against naturally occurring strains. Prophylaxis for contacts of pneumonic cases with
             doxycyline (100 mg po bid for 10 days) is necessary to prevent secondary transmission.                                                        Diagnosis: The clinical presentation of tularemia may be severe, yet non
                                                                                                                                      specific. Differential diagnoses include typhoidal syndromes (e.g., salmonella, rickettsia,
                                                                         malaria) or pneumonic processes (e.g., plague, mycoplasma, SEB). A clue to the diagnosis
                                                                                                                            i         of tularemia delivered as a biowufue weapon might be a large number of temporally
                     Vaccine: A licensed, formalin-killed Y. @s is vaccine is marketed in the U.S., and                               clustered patients presenting with similar systemic illnesses, a proportion of whom will have
             has been utilized by U.S. military personnel for many years in highly plague-endemic areas.                              a non-productive pneumonia.
             Vaccine effi@cy remains formally unproven, although anecdotal experience suggests it is
             effective against, at least, bubonic disease. R@ctogenicity is moderately high, and immunity                                     Specific Laboratory Diagnosis: Identification of organisms by staining ulcer fluids or
             acquired after a 3-dose primary series (0,1, and 4-7 months) is sustained only with boosters                             sputum is generally not helpful. Routine culture is difficult, due to unusual growth
             every 1-2 years. Live-attenuated vaccines produced in other countries are generally regarded                             requirements @d/or overgrowth of commensual bacteria. The diagnosis @ be established
             as highly rmctogenic, with a potential for reversion.                                                                    retrospectively by scrology.

                                                                                                                                              C.      TIIERAPY

is the treatment of choice.
                                                                                                                                      Gentamicin also is effective (3-5 mg/kg/day parenterally for 10-14 days). Tetracycline and
                                                       TULAREMIA                                                                      chloramphenicol treatment me effective as well, but are associated with a signific@t relapse
                                                                                                                                      rate. Although laboratory-related infections with this organism are very common, human-to
                     A.     CLINICAL SYNDROME                                                                                         human spread is unusual, and isolation is not required.

                     Tularemia is a zmnotic dismw caused by Fmcisella Ililarensis, a small, non spore-                                        D.      PROPIIYLAXIS
             forming gram negative bacillus. Hum@s acquire the disease under natural conditions
             through inoculation of skin or mucous membranes with blood or tissue fluids of infected                                          A live-attenuated tularemia vaccine is available as an invesdgadonal new dmg. This
             mimals, or bites of infected dmrflies, mosquitoes, or ticks. Less commonly, inhalation of                                vaccine has been administered to more than 5,000 persons without significant adverse
             contaminated dusts or ingestion of contaminated foods or water may produce clinical disease.                             reactions, and is of proven effectiveness in preventing labomtory-acquired typhoidal
             A biological warfare attack with F, tuluensis delivered by aerosol would primarily cause                                 tularemia.
                                                        The use of antibiotics for prophylaxis against tularemia is controversial.



                                                               86
                                                                                                                                                                                        87

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 52 f:/Week-36/BX003203/DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS/diagnosis and treatment of diseases of importanc:12179609281524
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS
Folder Seq # = 88
Subject = DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANC
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996